The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of option agreements

13 Jul 2007 07:30

Cubus Lux plc Extension of options to acquire certain development land known as the Olive Island Resort

On 13 March 2007, Cubus Lux plc (the "Company") announced that it had entered into two option agreements to acquire certain development land known as the "Olive Island Resort" on the coast of Dalmatia in Croatia. These options were originally for a four month term, expiring on 12 July 2007.

The Company entered into agreements on 12 July 2007 to extend these options for a further two months, expiring on 12 September 2007.

The Olive Island Resort development land is intended to be developed into a village resort comprising 126 villas and 305 apartments as well as accompanying facilities, such as restaurants, shops, offices and a marina (the "Villas Development"); and a four-star hotel containing 500 beds (the "Hotel Development").

Both option agreements are conditional upon a number of factors, including completion of due diligence by the Company, finalisation of the terms of acquisition and the raising of debt or equity financing by the Company for at least ¢â€š¬10 million. The exercise of the options is subject to appropriate consents having been granted by the government of Croatia.

Highlights, as announced on 13 March 2007:

* Option to acquire the Villas Development for ¢â€š¬10 million in cash and the issue of 33 million ordinary shares in the Company.

* Option to acquire the Hotel Development for ¢â€š¬5 million in ordinary shares of the Company.

* Independent valuation by UK based surveyors Kings Sturge of the Villas Development at ¢â€š¬39 million and the Hotel Development at ¢â€š¬5 million.

In the event that the Company proceeds with the acquisition of the Villas Development and the Hotel Development, the transaction is expected to constitute a reverse takeover for the purposes of the AIM Rules, and will therefore require the issue of an admission document and shareholder approval. In addition, the transaction would be considered to be a related party transaction for the purposes of the AIM Rules due to the connection between Gerhard Huber, Michael Janssen and Christian Kaiser (directors of the Company) and the counterparties to the option agreements.

For further information please contact:

Leon Nahon +44 (0)7920 834 156Cubus Lux plcRoss Andrews/Simon Sacerdoti +44 (0)20 7090 7800City Financial Associates LimitedGraham Herring/Josh Royston +44 (0)20 7936 9605Threadneedle Communications Limited

CUBUS LUX PLC
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.